Healthlead PCL (BKK:HL)

Market Cap	1.87B -31.4%
Revenue (ttm)	2.23B +16.0%
Net Income	81.23M +5.8%
EPS	0.30 +6.5%
Shares Out	259.25M
PE Ratio	23.96
Forward PE	n/a
Dividend	0.17 (2.38%)
Ex-Dividend Date	Mar 14, 2025

Volume	47,100
Average Volume	113,101
Open	7.15
Previous Close	7.15
Day's Range	7.15 - 7.20
52-Week Range	5.40 - 8.95
Beta	0.27
RSI	59.20
Earnings Date	Feb 27, 2026

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, and Super Drug brands; and dietary supplements under the PRIME and Besuto brand names. Healthlead Public Company Limited was incorporated in 2018 and i...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 3
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2024, Healthlead PCL's revenue was 2.01 billion, an increase of 21.22% compared to the previous year's 1.66 billion. Earnings were 78.26 million, an increase of 4.80%.